ICM
CSTE icon

Invenomic Capital Management’s Caesarstone CSTE Stock Holding History

Invenomic Capital Management’s Portfolio CSTE Stock Details CSTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,046
Closed -$147K – 167
2024
Q1 		$147K Sell
36,046
-233,288
-87% -$955K 0.01% 145
2023
Q4 		$1.01M Sell
269,334
-103,422
-28% -$417K 0.05% 159
2023
Q3 		$1.6M Buy
372,756
+15,609
+4% +$75.2K 0.07% 134
2023
Q2 		$1.87M Sell
357,147
-99,403
-22% -$450K 0.09% 121
2023
Q1 		$1.89M Buy
456,550
+10,583
+2% +$58.7K 0.11% 125
2022
Q4 		$2.55M Sell
445,967
-39,496
-8% -$295K 0.17% 116
2022
Q3 		$4.52M Sell
485,463
-17,106
-3% -$165K 0.39% 83
2022
Q2 		$4.59M Buy
502,569
+2,811
+0.6% +$26.9K 0.33% 84
2022
Q1 		$4.2M Buy
499,758
+142,473
+40% +$1.69M 0.45% 68
2021
Q4 		$4.05M Buy
357,285
+98,925
+38% +$1.19M 0.87% 42
2021
Q3 		$3.21M Buy
258,360
+66,659
+35% +$895K 1.04% 33
2021
Q2 		$2.83M Sell
191,701
-53,459
-22% -$808K 0.68% 36
2021
Q1 		$3.37M Buy
245,160
+17,558
+8% +$232K 0.75% 26
2020
Q4 		$2.93M Buy
227,602
+120,712
+113% +$1.38M 0.75% 21
2020
Q3 		$1.05M Buy
106,890
+67,096
+169% +$724K 0.58% 55
2020
Q2 		$472K Buy
39,794
+12,559
+46% +$132K 0.35% 87
2020
Q1 		$288K Buy
+27,235
New +$332K 0.24% 101

Other funds holding CSTE

PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invenomic Capital Management's CSTE Position: Q2 2024 in Review

Invenomic Capital Management sold out of Caesarstone (CSTE) in Q2 2024, closing a stake of 36,046 shares — an estimated $147K sold.

Invenomic Capital Management first reported a position in CSTE in Q1 2020 and held it in 17 quarters. The position peaked at $4.59M in Q2 2022. 68 funds tracked by Wall St. Rank hold CSTE as of Q2 2024.

  • Invenomic Capital Management reported no remaining Caesarstone position as of Q2 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 36,046 Caesarstone shares in Q2 2024, an estimated $147K.
  • Invenomic Capital Management first reported a position in Caesarstone in Q1 2020 and held it in 17 quarters.
  • Invenomic Capital Management's Caesarstone position peaked at $4.59M in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Caesarstone as of Q2 2024.

Based on Invenomic Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.